Global Therapeutic Nuclear Drug Market Research Report 2023
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
According to QYResearch’s new survey, global Therapeutic Nuclear Drug market is projected to reach US$ 4734 million in 2029, increasing from US$ 1771 million in 2022, with the CAGR of 15.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Therapeutic Nuclear Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Therapeutic Nuclear Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
According to QYResearch’s new survey, global Therapeutic Nuclear Drug market is projected to reach US$ 4734 million in 2029, increasing from US$ 1771 million in 2022, with the CAGR of 15.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Therapeutic Nuclear Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Therapeutic Nuclear Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Bayer
- Novartis
- China Isotope & Radiation
- Dongcheng
- Q BioMed
- Curium Pharmaceuticals
- Jubilant Radiopharma
- Lantheus
- Aurobindo Pharma
- International Isotopes
- Mundipharma
- Radium-223
- Lutetium-177
- Iodine-131
- Other
- Thyroid
- Bone Metastasis
- Lymphoma
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Nuclear Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Market by Application
1.3.1 Global Therapeutic Nuclear Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Therapeutic Nuclear Drug Market Perspective (2018-2029)
2.2 Therapeutic Nuclear Drug Growth Trends by Region
2.2.1 Global Therapeutic Nuclear Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Therapeutic Nuclear Drug Historic Market Size by Region (2018-2023)
2.2.3 Therapeutic Nuclear Drug Forecasted Market Size by Region (2024-2029)
2.3 Therapeutic Nuclear Drug Market Dynamics
2.3.1 Therapeutic Nuclear Drug Industry Trends
2.3.2 Therapeutic Nuclear Drug Market Drivers
2.3.3 Therapeutic Nuclear Drug Market Challenges
2.3.4 Therapeutic Nuclear Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Therapeutic Nuclear Drug Players by Revenue
3.1.1 Global Top Therapeutic Nuclear Drug Players by Revenue (2018-2023)
3.1.2 Global Therapeutic Nuclear Drug Revenue Market Share by Players (2018-2023)
3.2 Global Therapeutic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Therapeutic Nuclear Drug Revenue
3.4 Global Therapeutic Nuclear Drug Market Concentration Ratio
3.4.1 Global Therapeutic Nuclear Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Nuclear Drug Revenue in 2022
3.5 Therapeutic Nuclear Drug Key Players Head office and Area Served
3.6 Key Players Therapeutic Nuclear Drug Product Solution and Service
3.7 Date of Enter into Therapeutic Nuclear Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 THERAPEUTIC NUCLEAR DRUG BREAKDOWN DATA BY TYPE
4.1 Global Therapeutic Nuclear Drug Historic Market Size by Type (2018-2023)
4.2 Global Therapeutic Nuclear Drug Forecasted Market Size by Type (2024-2029)
5 THERAPEUTIC NUCLEAR DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global Therapeutic Nuclear Drug Historic Market Size by Application (2018-2023)
5.2 Global Therapeutic Nuclear Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Therapeutic Nuclear Drug Market Size (2018-2029)
6.2 North America Therapeutic Nuclear Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Therapeutic Nuclear Drug Market Size by Country (2018-2023)
6.4 North America Therapeutic Nuclear Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Therapeutic Nuclear Drug Market Size (2018-2029)
7.2 Europe Therapeutic Nuclear Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Therapeutic Nuclear Drug Market Size by Country (2018-2023)
7.4 Europe Therapeutic Nuclear Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Therapeutic Nuclear Drug Market Size (2018-2029)
8.2 Asia-Pacific Therapeutic Nuclear Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Therapeutic Nuclear Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Therapeutic Nuclear Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Therapeutic Nuclear Drug Market Size (2018-2029)
9.2 Latin America Therapeutic Nuclear Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Therapeutic Nuclear Drug Market Size by Country (2018-2023)
9.4 Latin America Therapeutic Nuclear Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Therapeutic Nuclear Drug Market Size (2018-2029)
10.2 Middle East & Africa Therapeutic Nuclear Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Therapeutic Nuclear Drug Introduction
11.1.4 Bayer Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.1.5 Bayer Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Therapeutic Nuclear Drug Introduction
11.2.4 Novartis Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Company Detail
11.3.2 China Isotope & Radiation Business Overview
11.3.3 China Isotope & Radiation Therapeutic Nuclear Drug Introduction
11.3.4 China Isotope & Radiation Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.3.5 China Isotope & Radiation Recent Development
11.4 Dongcheng
11.4.1 Dongcheng Company Detail
11.4.2 Dongcheng Business Overview
11.4.3 Dongcheng Therapeutic Nuclear Drug Introduction
11.4.4 Dongcheng Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.4.5 Dongcheng Recent Development
11.5 Q BioMed
11.5.1 Q BioMed Company Detail
11.5.2 Q BioMed Business Overview
11.5.3 Q BioMed Therapeutic Nuclear Drug Introduction
11.5.4 Q BioMed Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.5.5 Q BioMed Recent Development
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Company Detail
11.6.2 Curium Pharmaceuticals Business Overview
11.6.3 Curium Pharmaceuticals Therapeutic Nuclear Drug Introduction
11.6.4 Curium Pharmaceuticals Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.6.5 Curium Pharmaceuticals Recent Development
11.7 Jubilant Radiopharma
11.7.1 Jubilant Radiopharma Company Detail
11.7.2 Jubilant Radiopharma Business Overview
11.7.3 Jubilant Radiopharma Therapeutic Nuclear Drug Introduction
11.7.4 Jubilant Radiopharma Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.7.5 Jubilant Radiopharma Recent Development
11.8 Lantheus
11.8.1 Lantheus Company Detail
11.8.2 Lantheus Business Overview
11.8.3 Lantheus Therapeutic Nuclear Drug Introduction
11.8.4 Lantheus Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.8.5 Lantheus Recent Development
11.9 Aurobindo Pharma
11.9.1 Aurobindo Pharma Company Detail
11.9.2 Aurobindo Pharma Business Overview
11.9.3 Aurobindo Pharma Therapeutic Nuclear Drug Introduction
11.9.4 Aurobindo Pharma Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.9.5 Aurobindo Pharma Recent Development
11.10 International Isotopes
11.10.1 International Isotopes Company Detail
11.10.2 International Isotopes Business Overview
11.10.3 International Isotopes Therapeutic Nuclear Drug Introduction
11.10.4 International Isotopes Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.10.5 International Isotopes Recent Development
11.11 Mundipharma
11.11.1 Mundipharma Company Detail
11.11.2 Mundipharma Business Overview
11.11.3 Mundipharma Therapeutic Nuclear Drug Introduction
11.11.4 Mundipharma Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.11.5 Mundipharma Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Nuclear Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Market by Application
1.3.1 Global Therapeutic Nuclear Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Therapeutic Nuclear Drug Market Perspective (2018-2029)
2.2 Therapeutic Nuclear Drug Growth Trends by Region
2.2.1 Global Therapeutic Nuclear Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Therapeutic Nuclear Drug Historic Market Size by Region (2018-2023)
2.2.3 Therapeutic Nuclear Drug Forecasted Market Size by Region (2024-2029)
2.3 Therapeutic Nuclear Drug Market Dynamics
2.3.1 Therapeutic Nuclear Drug Industry Trends
2.3.2 Therapeutic Nuclear Drug Market Drivers
2.3.3 Therapeutic Nuclear Drug Market Challenges
2.3.4 Therapeutic Nuclear Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Therapeutic Nuclear Drug Players by Revenue
3.1.1 Global Top Therapeutic Nuclear Drug Players by Revenue (2018-2023)
3.1.2 Global Therapeutic Nuclear Drug Revenue Market Share by Players (2018-2023)
3.2 Global Therapeutic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Therapeutic Nuclear Drug Revenue
3.4 Global Therapeutic Nuclear Drug Market Concentration Ratio
3.4.1 Global Therapeutic Nuclear Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Nuclear Drug Revenue in 2022
3.5 Therapeutic Nuclear Drug Key Players Head office and Area Served
3.6 Key Players Therapeutic Nuclear Drug Product Solution and Service
3.7 Date of Enter into Therapeutic Nuclear Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 THERAPEUTIC NUCLEAR DRUG BREAKDOWN DATA BY TYPE
4.1 Global Therapeutic Nuclear Drug Historic Market Size by Type (2018-2023)
4.2 Global Therapeutic Nuclear Drug Forecasted Market Size by Type (2024-2029)
5 THERAPEUTIC NUCLEAR DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global Therapeutic Nuclear Drug Historic Market Size by Application (2018-2023)
5.2 Global Therapeutic Nuclear Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Therapeutic Nuclear Drug Market Size (2018-2029)
6.2 North America Therapeutic Nuclear Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Therapeutic Nuclear Drug Market Size by Country (2018-2023)
6.4 North America Therapeutic Nuclear Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Therapeutic Nuclear Drug Market Size (2018-2029)
7.2 Europe Therapeutic Nuclear Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Therapeutic Nuclear Drug Market Size by Country (2018-2023)
7.4 Europe Therapeutic Nuclear Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Therapeutic Nuclear Drug Market Size (2018-2029)
8.2 Asia-Pacific Therapeutic Nuclear Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Therapeutic Nuclear Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Therapeutic Nuclear Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Therapeutic Nuclear Drug Market Size (2018-2029)
9.2 Latin America Therapeutic Nuclear Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Therapeutic Nuclear Drug Market Size by Country (2018-2023)
9.4 Latin America Therapeutic Nuclear Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Therapeutic Nuclear Drug Market Size (2018-2029)
10.2 Middle East & Africa Therapeutic Nuclear Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Therapeutic Nuclear Drug Introduction
11.1.4 Bayer Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.1.5 Bayer Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Therapeutic Nuclear Drug Introduction
11.2.4 Novartis Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Company Detail
11.3.2 China Isotope & Radiation Business Overview
11.3.3 China Isotope & Radiation Therapeutic Nuclear Drug Introduction
11.3.4 China Isotope & Radiation Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.3.5 China Isotope & Radiation Recent Development
11.4 Dongcheng
11.4.1 Dongcheng Company Detail
11.4.2 Dongcheng Business Overview
11.4.3 Dongcheng Therapeutic Nuclear Drug Introduction
11.4.4 Dongcheng Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.4.5 Dongcheng Recent Development
11.5 Q BioMed
11.5.1 Q BioMed Company Detail
11.5.2 Q BioMed Business Overview
11.5.3 Q BioMed Therapeutic Nuclear Drug Introduction
11.5.4 Q BioMed Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.5.5 Q BioMed Recent Development
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Company Detail
11.6.2 Curium Pharmaceuticals Business Overview
11.6.3 Curium Pharmaceuticals Therapeutic Nuclear Drug Introduction
11.6.4 Curium Pharmaceuticals Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.6.5 Curium Pharmaceuticals Recent Development
11.7 Jubilant Radiopharma
11.7.1 Jubilant Radiopharma Company Detail
11.7.2 Jubilant Radiopharma Business Overview
11.7.3 Jubilant Radiopharma Therapeutic Nuclear Drug Introduction
11.7.4 Jubilant Radiopharma Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.7.5 Jubilant Radiopharma Recent Development
11.8 Lantheus
11.8.1 Lantheus Company Detail
11.8.2 Lantheus Business Overview
11.8.3 Lantheus Therapeutic Nuclear Drug Introduction
11.8.4 Lantheus Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.8.5 Lantheus Recent Development
11.9 Aurobindo Pharma
11.9.1 Aurobindo Pharma Company Detail
11.9.2 Aurobindo Pharma Business Overview
11.9.3 Aurobindo Pharma Therapeutic Nuclear Drug Introduction
11.9.4 Aurobindo Pharma Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.9.5 Aurobindo Pharma Recent Development
11.10 International Isotopes
11.10.1 International Isotopes Company Detail
11.10.2 International Isotopes Business Overview
11.10.3 International Isotopes Therapeutic Nuclear Drug Introduction
11.10.4 International Isotopes Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.10.5 International Isotopes Recent Development
11.11 Mundipharma
11.11.1 Mundipharma Company Detail
11.11.2 Mundipharma Business Overview
11.11.3 Mundipharma Therapeutic Nuclear Drug Introduction
11.11.4 Mundipharma Revenue in Therapeutic Nuclear Drug Business (2018-2023)
11.11.5 Mundipharma Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Therapeutic Nuclear Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Radium-223
Table 3. Key Players of Lutetium-177
Table 4. Key Players of Iodine-131
Table 5. Key Players of Other
Table 6. Global Therapeutic Nuclear Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Therapeutic Nuclear Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Therapeutic Nuclear Drug Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Therapeutic Nuclear Drug Market Share by Region (2018-2023)
Table 10. Global Therapeutic Nuclear Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Therapeutic Nuclear Drug Market Share by Region (2024-2029)
Table 12. Therapeutic Nuclear Drug Market Trends
Table 13. Therapeutic Nuclear Drug Market Drivers
Table 14. Therapeutic Nuclear Drug Market Challenges
Table 15. Therapeutic Nuclear Drug Market Restraints
Table 16. Global Therapeutic Nuclear Drug Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Therapeutic Nuclear Drug Market Share by Players (2018-2023)
Table 18. Global Top Therapeutic Nuclear Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Nuclear Drug as of 2022)
Table 19. Ranking of Global Top Therapeutic Nuclear Drug Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Therapeutic Nuclear Drug Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Therapeutic Nuclear Drug Product Solution and Service
Table 23. Date of Enter into Therapeutic Nuclear Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Therapeutic Nuclear Drug Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Therapeutic Nuclear Drug Revenue Market Share by Type (2018-2023)
Table 27. Global Therapeutic Nuclear Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Therapeutic Nuclear Drug Revenue Market Share by Type (2024-2029)
Table 29. Global Therapeutic Nuclear Drug Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Therapeutic Nuclear Drug Revenue Market Share by Application (2018-2023)
Table 31. Global Therapeutic Nuclear Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Therapeutic Nuclear Drug Revenue Market Share by Application (2024-2029)
Table 33. North America Therapeutic Nuclear Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Therapeutic Nuclear Drug Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Therapeutic Nuclear Drug Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Therapeutic Nuclear Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Therapeutic Nuclear Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Therapeutic Nuclear Drug Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Therapeutic Nuclear Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Therapeutic Nuclear Drug Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Therapeutic Nuclear Drug Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Therapeutic Nuclear Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Therapeutic Nuclear Drug Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Therapeutic Nuclear Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Therapeutic Nuclear Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2024-2029) & (US$ Million)
Table 48. Bayer Company Detail
Table 49. Bayer Business Overview
Table 50. Bayer Therapeutic Nuclear Drug Product
Table 51. Bayer Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 52. Bayer Recent Development
Table 53. Novartis Company Detail
Table 54. Novartis Business Overview
Table 55. Novartis Therapeutic Nuclear Drug Product
Table 56. Novartis Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 57. Novartis Recent Development
Table 58. China Isotope & Radiation Company Detail
Table 59. China Isotope & Radiation Business Overview
Table 60. China Isotope & Radiation Therapeutic Nuclear Drug Product
Table 61. China Isotope & Radiation Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 62. China Isotope & Radiation Recent Development
Table 63. Dongcheng Company Detail
Table 64. Dongcheng Business Overview
Table 65. Dongcheng Therapeutic Nuclear Drug Product
Table 66. Dongcheng Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 67. Dongcheng Recent Development
Table 68. Q BioMed Company Detail
Table 69. Q BioMed Business Overview
Table 70. Q BioMed Therapeutic Nuclear Drug Product
Table 71. Q BioMed Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 72. Q BioMed Recent Development
Table 73. Curium Pharmaceuticals Company Detail
Table 74. Curium Pharmaceuticals Business Overview
Table 75. Curium Pharmaceuticals Therapeutic Nuclear Drug Product
Table 76. Curium Pharmaceuticals Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 77. Curium Pharmaceuticals Recent Development
Table 78. Jubilant Radiopharma Company Detail
Table 79. Jubilant Radiopharma Business Overview
Table 80. Jubilant Radiopharma Therapeutic Nuclear Drug Product
Table 81. Jubilant Radiopharma Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 82. Jubilant Radiopharma Recent Development
Table 83. Lantheus Company Detail
Table 84. Lantheus Business Overview
Table 85. Lantheus Therapeutic Nuclear Drug Product
Table 86. Lantheus Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 87. Lantheus Recent Development
Table 88. Aurobindo Pharma Company Detail
Table 89. Aurobindo Pharma Business Overview
Table 90. Aurobindo Pharma Therapeutic Nuclear Drug Product
Table 91. Aurobindo Pharma Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 92. Aurobindo Pharma Recent Development
Table 93. International Isotopes Company Detail
Table 94. International Isotopes Business Overview
Table 95. International Isotopes Therapeutic Nuclear Drug Product
Table 96. International Isotopes Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 97. International Isotopes Recent Development
Table 98. Mundipharma Company Detail
Table 99. Mundipharma Business Overview
Table 100. Mundipharma Therapeutic Nuclear Drug Product
Table 101. Mundipharma Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 102. Mundipharma Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 1. Global Therapeutic Nuclear Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Radium-223
Table 3. Key Players of Lutetium-177
Table 4. Key Players of Iodine-131
Table 5. Key Players of Other
Table 6. Global Therapeutic Nuclear Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Therapeutic Nuclear Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Therapeutic Nuclear Drug Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Therapeutic Nuclear Drug Market Share by Region (2018-2023)
Table 10. Global Therapeutic Nuclear Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Therapeutic Nuclear Drug Market Share by Region (2024-2029)
Table 12. Therapeutic Nuclear Drug Market Trends
Table 13. Therapeutic Nuclear Drug Market Drivers
Table 14. Therapeutic Nuclear Drug Market Challenges
Table 15. Therapeutic Nuclear Drug Market Restraints
Table 16. Global Therapeutic Nuclear Drug Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Therapeutic Nuclear Drug Market Share by Players (2018-2023)
Table 18. Global Top Therapeutic Nuclear Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Nuclear Drug as of 2022)
Table 19. Ranking of Global Top Therapeutic Nuclear Drug Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Therapeutic Nuclear Drug Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Therapeutic Nuclear Drug Product Solution and Service
Table 23. Date of Enter into Therapeutic Nuclear Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Therapeutic Nuclear Drug Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Therapeutic Nuclear Drug Revenue Market Share by Type (2018-2023)
Table 27. Global Therapeutic Nuclear Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Therapeutic Nuclear Drug Revenue Market Share by Type (2024-2029)
Table 29. Global Therapeutic Nuclear Drug Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Therapeutic Nuclear Drug Revenue Market Share by Application (2018-2023)
Table 31. Global Therapeutic Nuclear Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Therapeutic Nuclear Drug Revenue Market Share by Application (2024-2029)
Table 33. North America Therapeutic Nuclear Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Therapeutic Nuclear Drug Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Therapeutic Nuclear Drug Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Therapeutic Nuclear Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Therapeutic Nuclear Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Therapeutic Nuclear Drug Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Therapeutic Nuclear Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Therapeutic Nuclear Drug Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Therapeutic Nuclear Drug Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Therapeutic Nuclear Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Therapeutic Nuclear Drug Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Therapeutic Nuclear Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Therapeutic Nuclear Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2024-2029) & (US$ Million)
Table 48. Bayer Company Detail
Table 49. Bayer Business Overview
Table 50. Bayer Therapeutic Nuclear Drug Product
Table 51. Bayer Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 52. Bayer Recent Development
Table 53. Novartis Company Detail
Table 54. Novartis Business Overview
Table 55. Novartis Therapeutic Nuclear Drug Product
Table 56. Novartis Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 57. Novartis Recent Development
Table 58. China Isotope & Radiation Company Detail
Table 59. China Isotope & Radiation Business Overview
Table 60. China Isotope & Radiation Therapeutic Nuclear Drug Product
Table 61. China Isotope & Radiation Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 62. China Isotope & Radiation Recent Development
Table 63. Dongcheng Company Detail
Table 64. Dongcheng Business Overview
Table 65. Dongcheng Therapeutic Nuclear Drug Product
Table 66. Dongcheng Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 67. Dongcheng Recent Development
Table 68. Q BioMed Company Detail
Table 69. Q BioMed Business Overview
Table 70. Q BioMed Therapeutic Nuclear Drug Product
Table 71. Q BioMed Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 72. Q BioMed Recent Development
Table 73. Curium Pharmaceuticals Company Detail
Table 74. Curium Pharmaceuticals Business Overview
Table 75. Curium Pharmaceuticals Therapeutic Nuclear Drug Product
Table 76. Curium Pharmaceuticals Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 77. Curium Pharmaceuticals Recent Development
Table 78. Jubilant Radiopharma Company Detail
Table 79. Jubilant Radiopharma Business Overview
Table 80. Jubilant Radiopharma Therapeutic Nuclear Drug Product
Table 81. Jubilant Radiopharma Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 82. Jubilant Radiopharma Recent Development
Table 83. Lantheus Company Detail
Table 84. Lantheus Business Overview
Table 85. Lantheus Therapeutic Nuclear Drug Product
Table 86. Lantheus Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 87. Lantheus Recent Development
Table 88. Aurobindo Pharma Company Detail
Table 89. Aurobindo Pharma Business Overview
Table 90. Aurobindo Pharma Therapeutic Nuclear Drug Product
Table 91. Aurobindo Pharma Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 92. Aurobindo Pharma Recent Development
Table 93. International Isotopes Company Detail
Table 94. International Isotopes Business Overview
Table 95. International Isotopes Therapeutic Nuclear Drug Product
Table 96. International Isotopes Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 97. International Isotopes Recent Development
Table 98. Mundipharma Company Detail
Table 99. Mundipharma Business Overview
Table 100. Mundipharma Therapeutic Nuclear Drug Product
Table 101. Mundipharma Revenue in Therapeutic Nuclear Drug Business (2018-2023) & (US$ Million)
Table 102. Mundipharma Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Therapeutic Nuclear Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Therapeutic Nuclear Drug Market Share by Type: 2022 VS 2029
Figure 3. Radium-223 Features
Figure 4. Lutetium-177 Features
Figure 5. Iodine-131 Features
Figure 6. Other Features
Figure 7. Global Therapeutic Nuclear Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Therapeutic Nuclear Drug Market Share by Application: 2022 VS 2029
Figure 9. Thyroid Case Studies
Figure 10. Bone Metastasis Case Studies
Figure 11. Lymphoma Case Studies
Figure 12. Other Case Studies
Figure 13. Therapeutic Nuclear Drug Report Years Considered
Figure 14. Global Therapeutic Nuclear Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Therapeutic Nuclear Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Therapeutic Nuclear Drug Market Share by Region: 2022 VS 2029
Figure 17. Global Therapeutic Nuclear Drug Market Share by Players in 2022
Figure 18. Global Top Therapeutic Nuclear Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Nuclear Drug as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Therapeutic Nuclear Drug Revenue in 2022
Figure 20. North America Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Therapeutic Nuclear Drug Market Share by Country (2018-2029)
Figure 22. United States Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Therapeutic Nuclear Drug Market Share by Country (2018-2029)
Figure 26. Germany Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Therapeutic Nuclear Drug Market Share by Region (2018-2029)
Figure 34. China Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Therapeutic Nuclear Drug Market Share by Country (2018-2029)
Figure 42. Mexico Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Therapeutic Nuclear Drug Market Share by Country (2018-2029)
Figure 46. Turkey Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Bayer Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 50. China Isotope & Radiation Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 51. Dongcheng Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 52. Q BioMed Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 53. Curium Pharmaceuticals Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 54. Jubilant Radiopharma Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 55. Lantheus Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 56. Aurobindo Pharma Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 57. International Isotopes Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 58. Mundipharma Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Figure 1. Global Therapeutic Nuclear Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Therapeutic Nuclear Drug Market Share by Type: 2022 VS 2029
Figure 3. Radium-223 Features
Figure 4. Lutetium-177 Features
Figure 5. Iodine-131 Features
Figure 6. Other Features
Figure 7. Global Therapeutic Nuclear Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Therapeutic Nuclear Drug Market Share by Application: 2022 VS 2029
Figure 9. Thyroid Case Studies
Figure 10. Bone Metastasis Case Studies
Figure 11. Lymphoma Case Studies
Figure 12. Other Case Studies
Figure 13. Therapeutic Nuclear Drug Report Years Considered
Figure 14. Global Therapeutic Nuclear Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Therapeutic Nuclear Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Therapeutic Nuclear Drug Market Share by Region: 2022 VS 2029
Figure 17. Global Therapeutic Nuclear Drug Market Share by Players in 2022
Figure 18. Global Top Therapeutic Nuclear Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Nuclear Drug as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Therapeutic Nuclear Drug Revenue in 2022
Figure 20. North America Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Therapeutic Nuclear Drug Market Share by Country (2018-2029)
Figure 22. United States Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Therapeutic Nuclear Drug Market Share by Country (2018-2029)
Figure 26. Germany Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Therapeutic Nuclear Drug Market Share by Region (2018-2029)
Figure 34. China Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Therapeutic Nuclear Drug Market Share by Country (2018-2029)
Figure 42. Mexico Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Therapeutic Nuclear Drug Market Share by Country (2018-2029)
Figure 46. Turkey Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Bayer Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 50. China Isotope & Radiation Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 51. Dongcheng Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 52. Q BioMed Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 53. Curium Pharmaceuticals Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 54. Jubilant Radiopharma Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 55. Lantheus Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 56. Aurobindo Pharma Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 57. International Isotopes Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 58. Mundipharma Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
